AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
208.38
-0.61 (-0.29%)
At close: Apr 17, 2026, 4:00 PM EDT
208.99
+0.61 (0.29%)
After-hours: Apr 17, 2026, 7:58 PM EDT
AbbVie Stock Forecast
Stock Price Forecast
The 18 analysts that cover AbbVie stock have a consensus rating of "Buy" and an average price target of $250.56, which forecasts a 20.24% increase in the stock price over the next year. The lowest target is $204 and the highest is $299.
Price Target: $250.56 (+20.24%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AbbVie stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 4 | 4 | 4 |
| Buy | 11 | 9 | 9 | 10 | 10 | 10 |
| Hold | 6 | 5 | 7 | 6 | 6 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 19 | 21 | 20 | 20 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $242 → $249 | Strong Buy | Maintains | $242 → $249 | +19.49% | Apr 10, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $250 → $240 | Buy | Maintains | $250 → $240 | +15.17% | Apr 8, 2026 |
| RBC Capital | RBC Capital | Buy Initiates $260 | Buy | Initiates | $260 | +24.77% | Feb 25, 2026 |
| Barclays | Barclays | Buy Initiates $275 | Buy | Initiates | $275 | +31.97% | Feb 20, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $289 → $299 | Buy | Maintains | $289 → $299 | +43.49% | Feb 18, 2026 |
Financial Forecast
Revenue This Year
68.42B
from 61.16B
Increased by 11.87%
Revenue Next Year
73.98B
from 68.42B
Increased by 8.12%
EPS This Year
14.83
from 2.36
Increased by 528.36%
EPS Next Year
16.41
from 14.83
Increased by 10.66%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 70.9B | 78.0B | |||
| Avg | 68.4B | 74.0B | |||
| Low | 65.3B | 69.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 15.9% | 14.0% | |||
| Avg | 11.9% | 8.1% | |||
| Low | 6.7% | 0.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 16.01 | 18.30 | |||
| Avg | 14.83 | 16.41 | |||
| Low | 13.75 | 14.65 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 578.5% | 23.4% | |||
| Avg | 528.4% | 10.7% | |||
| Low | 482.6% | -1.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.